Answers are grounded in this paper and cite their sources.
Demonstrates a multi-assay screening strategy to identify Lol system inhibitors across chemical libraries, highlighting a viable pipeline for discovering Gram-negative antibacterial agents.
As the Lol system, which is involved in localization of lipoproteins, is essential for Escherichia coli growth and widely conserved among gram-negative bacteria, it is considered to be a promising target for the development of anti-gram-negative bacterial agents. However, no high-throughput screening method has so far been developed to screen for Lol system inhibitors. By combining three assay systems (anucleate cell blue assay, Lpp assay, and LolA-dependent release inhibition assay) and a drug susceptibility test, we have successfully developed a new screening method for identification of compounds that inhibit the Lol system. Using this new screening method, we screened 23,600 in-house chemical compounds and found 2 Lol system inhibitors. We therefore conclude that our new screening method can efficiently identify new antibacterial agents that target the Lol system.
No takes yet. Share an insight, caveat, or question.
Ito et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: